Difficulty: Medium
Average Score: 73%
Practice
Barbiturates are contraindicated in a dental patient with: II. emphysema III. Undiagnosed severe pain III. hypertension IV. Acute intermittent porphyria
Correct answer
A
Rationale
In this scenario, the correct answer is A) I, III & IV - emphysema, hypertension, and acute intermittent porphyria are contraindications for using barbiturates in a dental patient.
Emphysema is a chronic lung condition where breathing is compromised. Barbiturates can further suppress respiratory function, exacerbating breathing difficulties in patients with emphysema.
Hypertension is a condition characterized by high blood pressure. Barbiturates can cause further elevation of blood pressure, leading to adverse cardiovascular events in patients with hypertension.
Acute intermittent porphyria is a genetic disorder affecting heme synthesis. Barbiturates can induce porphyrin production, exacerbating symptoms and potentially causing a porphyria crisis in patients with this condition.
Educationally, understanding contraindications of medications is crucial for safe and effective patient care. This knowledge ensures healthcare providers can make informed decisions to prevent adverse reactions and complications in vulnerable patient populations.
Emphysema is a chronic lung condition where breathing is compromised. Barbiturates can further suppress respiratory function, exacerbating breathing difficulties in patients with emphysema.
Hypertension is a condition characterized by high blood pressure. Barbiturates can cause further elevation of blood pressure, leading to adverse cardiovascular events in patients with hypertension.
Acute intermittent porphyria is a genetic disorder affecting heme synthesis. Barbiturates can induce porphyrin production, exacerbating symptoms and potentially causing a porphyria crisis in patients with this condition.
Educationally, understanding contraindications of medications is crucial for safe and effective patient care. This knowledge ensures healthcare providers can make informed decisions to prevent adverse reactions and complications in vulnerable patient populations.